Webinar: Perspectives on the FDA’s 2nd Patient-Focused Drug Development Guidance

The National Health Council and our member organizations present a webinar on the FDA’s second draft guidance in their series on patient-focused drug development.

Friday, Dec. 13, 2019 from 2 p.m. to 3 p.m. ET/ 11 a.m. - 12 p.m. PT

RSVP using the form below to receive dial-in information.
Please be sure to join 5 minutes prior to the start of the webinar.

The National Health Council is a long-time supporter of bringing the patient perspective to medical product development, and we are excited by the FDA's series of guidances for industry to further the science of patient engagement. Join us on Friday, Dec. 13 as we host a webinar to give our perspective on their draft second guidance and hear from two of our members, who will also give their perspective. 

Eleanor M. Perfetto, PhD, MS
Executive Vice President, Strategic Initiatives
National Health Council

Elisabeth Oehrlein, PhD, MS
Senior Director, Programs
National Health Council

Leslie Ritter, MA
Senior Director, Advocacy
National Multiple Sclerosis Society

Industry Presenter